Panbela Therapeutics, Inc. Q3 2023 Earnings Call Transcript
| PBLADelisted Stock | USD 2.06 0.11 5.07% |
About 62% of Panbela Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Panbela Therapeutics stock suggests that many investors are alarmed at this time. The current market sentiment, together with Panbela Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Panbela Therapeutics stock news signals to limit their universe of possible portfolio assets.
Panbela |
Panbela Therapeutics, Inc. Q3 2023 Earnings Call Transcript November 10, 2023 Operator Greetings, and welcome to the Panbela Therapeutics Third Quarter 2023 Earnings Call. Operator Instructions Please note this conference is being recorded. I will now turn the conference over to your host, James Carbonara, Investor Relations at Panbela. James, you may begin. James
Read at finance.yahoo.com
 |
Panbela Therapeutics Fundamental Analysis
We analyze Panbela Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Panbela Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Panbela Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Panbela Therapeutics is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Panbela Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Panbela Therapeutics stock to make a market-neutral strategy. Peer analysis of Panbela Therapeutics could also be used in its relative valuation, which is a method of valuing Panbela Therapeutics by comparing valuation metrics with similar companies.
Peers
Panbela Therapeutics Related Equities
| CYTO | Altamira Therapeutics | 7.50 | ||||
| QNRX | Quoin Pharmaceuticals | 1.69 | ||||
| PALI | Palisade Bio | 1.65 | ||||
| UNCY | Unicycive Therapeutics | 1.47 | ||||
| REVB | Revelation Biosciences | 1.33 | ||||
| SONN | Sonnet Biotherapeutics | 2.28 | ||||
| CDIO | Cardio Diagnostics | 3.23 | ||||
| ZVSA | ZyVersa Therapeutics | 3.60 | ||||
| VRAX | Virax Biolabs | 4.83 | ||||
| KPRX | Kiora Pharmaceuticals | 8.68 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Panbela Stock
If you are still planning to invest in Panbela Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Panbela Therapeutics' history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |